Implementing 5-dose Measles-Rubella Vaccine Vials in Zambia

From January 2017 through July 2018, the Dose Per Container Partnership (DPCP) conducted implementation research using quantitative and qualitative methods in Central and Luapula provinces in Zambia. The country was selected for this work because of Ministry of Health (MOH) interest and commitment to engaging in the implementation research; a functional supply chain; minimal regulatory barriers to introducing a new presentation; and support from in-country and regional partners.

The DPCP introduced 5-dose vials of measles-rubella (MR) vaccine to a select group of health facilities in May 2017 to assess the effects on the immunization system of reducing the number of DPC from the 10-dose vials in use. This report outlines those research findings.

The Dose Per Container Partnership is a project funded by the Bill & Melinda Gates Foundation (BMGF), led by JSI Research & Training Institute, Inc., and jointly implemented in partnership with PATH, the Clinton Health Access Initiative (CHAI), the Highly Extensible Resource for Modeling Event-Driven Supply Chains (HERMES) modeling team, and the International Vaccine Access Center (IVAC). DPCP supports better-informed decision making on doses per container (DPC). This final report outlines the researching findings in Zambia. JSI. 2019.